The primary structure of bovine growth hormone  by Wallis, M.
Volume 35, number 1 FEBS LETTERS September 1973 
THE PRIMARY STRUCTURE OF BOVINE GROWTH HORMONE 
M. WALLIS 
School of Biological Sciences, University of Sussex, 
Falmer, Brighton BNI 9QG, Sussex, England 
Received 30 May 197 3 
1. Introduction 
Pituitary growth hormone is a protein hormone of 
monomer molecular weight about 20 000. Structural 
studies have been carried out on growth hormones 
from several species, and have demonstrated substan- 
tial specific variation. Several groups have studied the 
amino acid sequence of bovine growth hormone [ l- 
71 ; SantomC et al. [3] gave an almost complete pri- 
mary structure. However, the sequences proposed by 
different research groups differ substantially. In this 
paper, our work on the complete sequence of this hor- 
mone is summarized. Particular attention is paid to 
points of difference from the results of other workers. 
The determination of amino acid sequences for 
growth hormones from different species is of particu- 
lar interest in relation to the molecular evolution of 
the hormone [5]. The availability of the sequences of 
growth hormones from several other species has been 
of help in confirming that of bovine growth hormone, 
by homology, but the data acquired for the bovine 
hormone is, by itself, sufficient to establish the com- 
plete primary structure. 
2. Experimental 
2.1. Materials 
Bovine growth hormone was prepared by the 
method of Wallis and Dixon [8]. Trypsin (TPCK- 
treated), cu-chymotrypsin (3 X crystallized), pepsin 
and carboxypeptidases A and B (diisopropyl phos- 
phorofluoridate treated) were from Worthington 
Biochemical Corporation. Thermolysin was from 
Calbiochem and subtilisin from Sigma Ltd. 
North-Holland Publishing Company - Amsterdam 
2.2. Enzymic and cyanogen bromide digests; prepara- 
tion of pep tides 
Before enzymic digestion, growth hormone was 
modified by (a) performic oxidation [9], (b) reduc- 
tion followed by aminoethylation [lo] or (c) car- 
boxymethylation of methionine residues [6] , some- 
times followed by performic oxidation [9]. 
Various digests of protein so modified were pre- 
pared, using trypsin, chymotrypsin, thermolysin, pep- 
sin or trypsin plus chymotrypsin. Details of the prep- 
aration of some of these digests have been presented 
elsewhere [6,11,12] . In each case, digestion was per- 
formed in a volatile buffer, for 6-8 hr at 37”C, using 
an enzyme: protein ratio of 1: 50. After digestion, in- 
soluble peptides were removed, and the soluble frac- 
tion was freeze-dried. 
The soluble peptides were fractionated by one of 
two main methods. The first involved gel filtration on 
Sephadex G-50 and G-25, followed by further purifi- 
cation of peptides by high voltage paper electrophore- 
sis and paper chromatography. The second purifica- 
tion method involved peptide mapping [6] , location 
of peptides by staining with very weak (0.005%) nin- 
hydrin solution and preparation of peptides directly 
from these maps by elution with 6 N HCl. This sec- 
ond method allowed small quantities (up to 100 
nmoles) of peptide to be prepared quite easily. 
Most of the enzymic digests gave an insoluble frac- 
tion. The insoluble peptides after trypsin digestion 
were fractionated by paper electrophoresis in 60% 
formic acid (in which they were completely soluble) 
or by paper chromatography in n-butanol/acetic acid/ 
water (31 l/ 1, by volume), in which some of the pep- 
tides were soluble. 
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F’ . 1 The primary structure of bovine growth hormone. Tl, T2, etc. indicate peptides derived from tryptic digests of the protein. 
indicate points of cleavage by chymotrypsin, thermolysin and cyanogen bromide, respectively (as indicated by pep- 
t!ideki~ol!+ted from digests of the whole protein). Disulphide bridges connect residues Cys 53-Cys 164 and Cys 181~Cys 189. 
Heterogeneity at residue 1 and residue 127 is discussed in the text. 
Growth hormone was also fragmented with cyano- 
gen bromide, using conditions described previously 
[4]. The peptides produced were fractionated by gel 
filtration. 
2.3. Characterization of peptides 
Amino acid compositions were determined, after 
hydrolysis in 6 N HCl(1 10°C, 24 hr, sealed tube; a 
trace of phenol was added to protect tyrosine), on a 
Locarte amino acid analyser. 
N-terminal amino acid residues were determined by 
the ‘dansyl’ method [ 131 and N-terminal sequences 
by the ‘dansyl’-Edman technique [ 141. C-terminal res- 
idues and sequences were investigated in some cases 
by the use of carboxypeptidases A and/or B. 
For characterization of large peptides, further en- 
zymic digestion was used in many cases, using subtil- 
isin or one of the enzymes already mentioned. Such 
secondary digests were fractionated by the methods 
outlined. In some cases unfractioned digests were in- 
vestigated, using the ‘dansyl’-Edman method, and the 
approach advocated by Gray [ IS] . 
Location of amide groups was carried out mainly 
by investigating the mobility of peptides on electro- 
phoresis at pH 6.5. In some cases the mobility of 
‘dansyl’-peptides during ‘dansyl’-Edman degradation 
was investigated; in other cases amide assignments 
were based on the products of hydrolysis of peptides 
by leucine aminopeptidase or carboxypeptidase. 
12 
Volume 35, number 1 FEBS LElTERS September 1973 
3. Results 4. Discussion 
‘Ihe sequence derived for bovine growth hormone 
is shown in fig. 1. The polypeptide chain contains 191 
amino acid residues, though one of these, the N-ter- 
minal alanine, is missing from half of the polypeptide 
chains [4] . 
The bulk of the detailed sequence work was car- 
ried out on peptides derived from tryptic digests of 
the hormone. Most of the tryptic peptides were solu- 
ble, and could be fractionated quite readily. However, 
3 tryptic peptides, Tl, T5 and T8, were insoluble and 
proved difficult to fractionate, though Tl could be 
solubilized when prepared from growth hormone in 
which methionine residues had been carboxymethyl- 
ated, while T5 was split and solubilized when pre- 
pared from reduced and aminoethylated hormone. Tl, 
TS and T8 could be fractionated by paper electropho- 
resis in 6% formic acid, but yields were poor. 
Several groups have reported studies on the amino 
acid sequence of bovine growth hormone. The most 
nearly complete sequence published previously is 
that of Santome et al. [3]. There are several differ- 
ences between their sequence and that presented here. 
The main features concern the sequences of tryptic 
peptides T2 (differing at about 7 positions), T4 (dif- 
fering at 2 positions), T8 (about 7 differences) and 
Tl l-T12 (residues 113-124). In addition amide resi- 
dues have been located at positions 48 and 69 where- 
as SantomC et al. placed free carboxyl groups at these 
positions. 
The order of the tryptic peptides in the growth hor- 
mone molecule was determined by analysis of pep- 
tides from chymotrypsin, thermolysin and cyanogen 
bromide digests. The results from the last of these 
agreed well with those of Fellows and Rogol [I] . The 
investigation of peptides from these digests provided 
further information about regions of the sequence 
which had not been fully clarified from the tryptic 
peptides. The products of a trypsin plus chymotryp- 
sin digest [6] also helped in analysis of these difficult 
regions of the sequence. The order of tryptic peptides 
derived from ‘overlapping’ peptides agreed complete- 
ly with that given by homology with human or sheep 
growth hormones. 
Fellows et al. [2] determined the N-terminal se- 
quence of bovine growth hormone, as far as residue 
44, using an amino acid sequenator. Their results are 
in complete agreement with those presented here. 
They also reported the sequence of residues 124- 191, 
which is also in full agreement with that determined 
in the present work. The sequence given by Dayhoff 
[7] is based on the results of all three groups working 
on this hormone. 
Heterogeneity of the growth hormone sequence 
was detected at two positions: the N-terminus (half 
the polypeptide chains lack the N-terminal alanine 
residue [4]) and residue 127 (where, in agreement 
with earlier reports [ 1,3,16] , both leucine and valine 
were found, in a ratio of about 2: 1). No evidence was 
found for heterogeneity elsewhere in the molecule, 
but it certainly cannot be completely ruled out on the 
basis of the present data. 
There are two cystine residues in bovine growth 
hormone, and therefore, two disulphide bridges. The 
location has been shown [ 1,3] to be Cys 53-Cys 164 
and Cys 18 1 -Cys 189, and this was confirmed in the 
present work. 
Li et al. [ 171 have presented a sequence for ovine 
growth hormone, which is very similar to that re- 
ported here for the bovine hormone. The only differ- 
ences are at positions 99 (aspartic acid in ovine 
growth hormone replaces asparagine in the bovine 
hormone) and 130 (valine in ovine growth hormone, 
glycine in the bovine hormone). In addition, the va- 
line/leucine microheterogeneity at residue 127 may 
not be present in the ovine hormone. An extended se- 
quence for the C-terminal region of ovine growth hor- 
mone has also been presented by Bellair [ 181 ; this 
agrees completely with that of Li et al. [ 171 . 
Fernhndez et al. [19] have presented a partial se- 
quence for ovine growth hormone, but this differs 
somewhat from that of Li et al. [17] . Dayhoff [7] 
summarizes other work on the ovine growth hor- 
mone sequence. In addition, Seavey et al. [ 161 also 
identified the difference at residue 130, from peptide 
mapping. Whether the difference at residue 99 is a 
real one must be in doubt, because ovine and bovine 
growth hormones behave in a very similar way on iso- 
electric focussing and polyacrylamide gel electropho- 
resis [20] ; one would expect that a single charge dif- 
ference due to an aspartic acid/asparagine substitu- 
tion would have a substantial effect on the isoelectric 
points of the hormones [ 121. 
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The comparison of ovine and bovine growth hor- 
mone sequences thus confirms earlier ideas that these 
two hormones are very similar; they differ only at one 
or two residues. Bovine growth hormone differs very 
substantially, however, from the human hormone 
[21,22] (at 35-40% of all residues) and quite sub- 
stantially from porcine growth hormone [23] (at 
least 10% of all residues). The sheep and cow are of 
course quite closely related, but the degree of similar- 
ity between their growth hormones is surprising in 
view of the differences seen between the human, pig 
and bovine hormones. The results confirm the idea, 
discussed previously [5] , that rates of molecular evo- 
lution in this group of protein hormones have varied 
widely. 
Acknowledgements 
I thank Mrs. Jennifer Dew and Mr. David Watson 
for expert technical assistance, and the Medical 
Research Council for a research grant. 
References 
[ 11 Fellows, R.E. and Rogol, A.D. (1969) J. Biol. Chem. 
244,1567. 
[ 21 Fellows, R.E., Rogol, A.D. and Mudge, A. (1972) in: 
Growth and Growth Hormone (Pecile, A. and 
Miiller, E.E., eds.), p. 42, Excerpta Medica, Amsterdam. 
[ 31 Santome, J.A., Dellacha, J.M., Paladini, AC., 
Wolfenstein, C.E.M., Peiia, C., Poskus, E., Daurat, S.T., 
Biscoglio, M.J., de Sed, Z.M.M. and Sangtlesa, A.V.F. 
(1971) FEBS Letters 16, 198. 
[4] Wallis, M. (1969) FEBS Letters 3, 118. 
[5] Wallis, M. (1971) Biochem. J. 125,54P. 
I61 Wallis. M. (1972) FEBS Letters 21. 118. 
i7j 
[81 
PI 
IlO1 
[Ill 
[W 
[I31 
iI41 
1151 
[I61 
[I71 
[IfA 
(191 
rw 
Atlas of Protein Sequence and St&me ( 1972) 
(Dayhoff, M.O. ed.) p. D-203, National Biomedical 
Research Foundation, Washington. 
Wallis, M. and Dixon, H.B.F. (1966) Biochem. J. 100, 
593. 
Hirs, C.H.W. (1956) J. Biol. Chem. 219,611. 
Raftery, M.A. and Cole, R.D. (1963) Biochem. Biophys. 
Res. Commun. 10,467. 
Wallis, M. (1966) Biochim. Biophys. Acta 115, 423. 
Wallis, M. (1973) Biochim. Biophys. Acta 318,388. 
Gray, W.R. (1972) in: Methods in Enzymology, 
(Him, C.H.W. andTimasheff, S.N., eds.), Vol. 25, p. 121, 
Academic Press, New York. 
Gray, W.R. (1972) in: Methods in Enzymology, 
(Him, C.H.W. and Timasheff, S.N., eds.), Vol. 25, p. 333, 
Academic Press, New York. 
Gray, W.R. (1968) Nature 220, 1300. 
Seavey, B.K., Smgh, R.N.P., Lewis, U.J. and 
Geschwind, 1.1. (1971) Biochem. Biophys. Res. 
Commun. 43,189. 
Li, C.H., Dixon, J.S., Gordon, D. and Knorr, J. (1972) 
Intl. J. Peptide Protein Res. 4, 151. 
Bellair, J.T. (1972) Biochem. Biophys. Res. Commun. 
46, 1128. 
Fernlndez, H.N., Peiia, C., Poskus, E., Biscoglio, MJ., 
Paladini. A.C.. Dellacha, J.M. and Santom6, J.A. 
(1972) FEBS Letters 25, 265. 
Ellis, S., Lorenson, M., Grindeland, R.E. and 
Callahan, P.X. (1972) in: Growth and Growth Hormone 
(Pecile, A. and Mnller, E.E., eds.), p. 55, Excerpta 
Medica, Amsterdam. 
[21] Li, C.H. and Dixon, J.S. (1971) Arch. Biochem. 
Biophys. 146, 233. 
[22] Niall, H.D. (1971) Nature New Biology 230, 90. 
[23] Mills, J.B. and Wilhelmi, A.E. (1972) in: Growth and 
Growth Hormone (Pecile, A. and Milller, E.E., eds.), 
p. 38, Excerpta Medica, Amsterdam. 
14 
